In prostate cancer, ABHD5 impairs cell proliferation, metastasis and EMT progression via facilitating aerobic glycolysis and inhibiting mitochondrial respiration (Chen et al. 2017). The gene discussed is ABHD5; the disease is prostate carcinoma.